Skip to main content
Top
Published in: BMC Clinical Pathology 1/2012

Open Access 01-12-2012 | Research article

N-cadherin expression in malignant germ cell tumours of the testis

Authors: Felix Bremmer, Bernhard Hemmerlein, Arne Strauss, Peter Burfeind, Paul Thelen, Heinz-Joachim Radzun, Carl Ludwig Behnes

Published in: BMC Clinical Pathology | Issue 1/2012

Login to get access

Abstract

Background

Testicular germ cell tumours (TGCTs) are the most common malignancy in young men aged 18–35 years. They are clinically and histologically subdivided into seminomas and non-seminomas. Cadherins are calcium-dependent transmembrane proteins of the group of adhesion proteins. They play a role in the stabilization of cell-cell contacts, the embryonic morphogenesis, in the maintenance of cell polarity and signal transduction. N-cadherin (CDH2), the neuronal cadherin, stimulates cell-cell contacts during migration and invasion of cells and is able to suppress tumour cell growth.

Methods

Tumour tissues were acquired from 113 male patients and investigated by immunohistochemistry, as were the three TGCT cell lines NCCIT, NTERA-2 and Tcam2. A monoclonal antibody against N-cadherin was used.

Results

Tumour-free testis and intratubular germ cell neoplasias (unclassified) (IGCNU) strongly expressed N-cadherin within the cytoplasm. In all seminomas investigated, N-cadherin expression displayed a membrane-bound location. In addition, the teratomas and yolk sac tumours investigated also differentially expressed N-cadherin. In contrast, no N-cadherin could be detected in any of the embryonal carcinomas and chorionic carcinomas examined. This expression pattern was also seen in the investigated mixed tumours consisting of seminomas, teratomas, and embryonal carcinoma.

Conclusions

N-cadherin expression can be used to differentiate embryonal carcinomas and chorionic carcinomas from other histological subtypes of TGCT.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rosen A, Jayram G, Drazer M, Eggener SE: Global trends in testicular cancer incidence and mortality. Eur Urol. 2011, 60 (2): 374-379. 10.1016/j.eururo.2011.05.004. Epub 2011/05/27CrossRefPubMed Rosen A, Jayram G, Drazer M, Eggener SE: Global trends in testicular cancer incidence and mortality. Eur Urol. 2011, 60 (2): 374-379. 10.1016/j.eururo.2011.05.004. Epub 2011/05/27CrossRefPubMed
2.
go back to reference Horwich A, Shipley J, Huddart R: Testicular germ-cell cancer. Lancet. 2006, 367 (9512): 754-765. 10.1016/S0140-6736(06)68305-0. Epub 2006/03/07CrossRefPubMed Horwich A, Shipley J, Huddart R: Testicular germ-cell cancer. Lancet. 2006, 367 (9512): 754-765. 10.1016/S0140-6736(06)68305-0. Epub 2006/03/07CrossRefPubMed
3.
go back to reference Hoei-Hansen CE, Nielsen JE, Almstrup K, Sonne SB, Graem N, Skakkebaek NE: Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004, 10 (24): 8521-8530. 10.1158/1078-0432.CCR-04-1285. Epub 2004/12/30CrossRef Hoei-Hansen CE, Nielsen JE, Almstrup K, Sonne SB, Graem N, Skakkebaek NE: Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004, 10 (24): 8521-8530. 10.1158/1078-0432.CCR-04-1285. Epub 2004/12/30CrossRef
4.
go back to reference Angst BD, Marcozzi C, Magee AI: The cadherin superfamily: diversity in form and function. J Cell Sci. 2001, 114 (Pt 4): 629-641. Epub 2001/02/15PubMed Angst BD, Marcozzi C, Magee AI: The cadherin superfamily: diversity in form and function. J Cell Sci. 2001, 114 (Pt 4): 629-641. Epub 2001/02/15PubMed
5.
go back to reference Potter E, Bergwitz C, Brabant G: The cadherin-catenin system: implications for growth and differentiation of endocrine tissues. Endocr Rev. 1999, 20 (2): 207-239. 10.1210/er.20.2.207. Epub 1999/04/16CrossRefPubMed Potter E, Bergwitz C, Brabant G: The cadherin-catenin system: implications for growth and differentiation of endocrine tissues. Endocr Rev. 1999, 20 (2): 207-239. 10.1210/er.20.2.207. Epub 1999/04/16CrossRefPubMed
6.
go back to reference Stemmler MP: Cadherins in development and cancer. Mol Biosyst. 2008, 4 (8): 835-850. 10.1039/b719215k. Epub 2008/07/18CrossRefPubMed Stemmler MP: Cadherins in development and cancer. Mol Biosyst. 2008, 4 (8): 835-850. 10.1039/b719215k. Epub 2008/07/18CrossRefPubMed
7.
go back to reference Gumbiner BM: Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol. 2005, 6 (8): 622-634. Epub 2005/07/19CrossRefPubMed Gumbiner BM: Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol. 2005, 6 (8): 622-634. Epub 2005/07/19CrossRefPubMed
8.
go back to reference El Sayegh TY, Kapus A, McCulloch CA: Beyond the epithelium: cadherin function in fibrous connective tissues. FEBS Lett. 2007, 581 (2): 167-174. 10.1016/j.febslet.2006.12.029. Epub 2007/01/16CrossRefPubMed El Sayegh TY, Kapus A, McCulloch CA: Beyond the epithelium: cadherin function in fibrous connective tissues. FEBS Lett. 2007, 581 (2): 167-174. 10.1016/j.febslet.2006.12.029. Epub 2007/01/16CrossRefPubMed
9.
go back to reference Takeichi M: The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development. 1988, 102 (4): 639-655. Epub 1988/04/01PubMed Takeichi M: The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development. 1988, 102 (4): 639-655. Epub 1988/04/01PubMed
10.
go back to reference Balsamo J, Arregui C, Leung T, Lilien J: The nonreceptor protein tyrosine phosphatase PTP1B binds to the cytoplasmic domain of N-cadherin and regulates the cadherin-actin linkage. J Cell Biol. 1998, 143 (2): 523-532. 10.1083/jcb.143.2.523. Epub 1998/10/24CrossRefPubMedPubMedCentral Balsamo J, Arregui C, Leung T, Lilien J: The nonreceptor protein tyrosine phosphatase PTP1B binds to the cytoplasmic domain of N-cadherin and regulates the cadherin-actin linkage. J Cell Biol. 1998, 143 (2): 523-532. 10.1083/jcb.143.2.523. Epub 1998/10/24CrossRefPubMedPubMedCentral
11.
go back to reference Puch S, Armeanu S, Kibler C, Johnson KR, Muller CA, Wheelock MJ: N-cadherin is developmentally regulated and functionally involved in early hematopoietic cell differentiation. J Cell Sci. 2001, 114 (Pt 8): 1567-1577. Epub 2001/04/03PubMed Puch S, Armeanu S, Kibler C, Johnson KR, Muller CA, Wheelock MJ: N-cadherin is developmentally regulated and functionally involved in early hematopoietic cell differentiation. J Cell Sci. 2001, 114 (Pt 8): 1567-1577. Epub 2001/04/03PubMed
12.
go back to reference Abutaily AS, Addis BJ, Roche WR: Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies. J Clin Pathol. 2002, 55 (9): 662-668. 10.1136/jcp.55.9.662. Epub 2002/08/27CrossRefPubMedPubMedCentral Abutaily AS, Addis BJ, Roche WR: Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies. J Clin Pathol. 2002, 55 (9): 662-668. 10.1136/jcp.55.9.662. Epub 2002/08/27CrossRefPubMedPubMedCentral
13.
go back to reference Thirkettle I, Harvey P, Hasleton PS, Ball RY, Warn RM: Immunoreactivity for cadherins, HGF/SF, met, and erbB-2 in pleural malignant mesotheliomas. Histopathology. 2000, 36 (6): 522-528. 10.1046/j.1365-2559.2000.00888.x. Epub 2000/06/10CrossRefPubMed Thirkettle I, Harvey P, Hasleton PS, Ball RY, Warn RM: Immunoreactivity for cadherins, HGF/SF, met, and erbB-2 in pleural malignant mesotheliomas. Histopathology. 2000, 36 (6): 522-528. 10.1046/j.1365-2559.2000.00888.x. Epub 2000/06/10CrossRefPubMed
14.
go back to reference Han AC, Peralta-Soler A, Knudsen KA, Wheelock MJ, Johnson KR, Salazar H: Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues. Hum Pathol. 1997, 28 (6): 641-645. 10.1016/S0046-8177(97)90171-4. Epub 1997/06/01CrossRefPubMed Han AC, Peralta-Soler A, Knudsen KA, Wheelock MJ, Johnson KR, Salazar H: Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues. Hum Pathol. 1997, 28 (6): 641-645. 10.1016/S0046-8177(97)90171-4. Epub 1997/06/01CrossRefPubMed
15.
go back to reference Laskin WB, Miettinen M: Epithelial-type and neural-type cadherin expression in malignant noncarcinomatous neoplasms with epithelioid features that involve the soft tissues. Arch Pathol Lab Med. 2002, 126 (4): 425-431. Epub 2002/03/20PubMed Laskin WB, Miettinen M: Epithelial-type and neural-type cadherin expression in malignant noncarcinomatous neoplasms with epithelioid features that involve the soft tissues. Arch Pathol Lab Med. 2002, 126 (4): 425-431. Epub 2002/03/20PubMed
16.
go back to reference Peralta Soler A, Knudsen KA, Tecson-Miguel A, McBrearty FX, Han AC, Salazar H: Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors. Hum Pathol. 1997, 28 (6): 734-739. 10.1016/S0046-8177(97)90184-2. Epub 1997/06/01CrossRefPubMed Peralta Soler A, Knudsen KA, Tecson-Miguel A, McBrearty FX, Han AC, Salazar H: Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors. Hum Pathol. 1997, 28 (6): 734-739. 10.1016/S0046-8177(97)90184-2. Epub 1997/06/01CrossRefPubMed
17.
go back to reference Markovic-Lipkovski J, Brasanac D, Muller GA, Muller CA: Cadherins and integrins in renal cell carcinoma: an immunohistochemical study. Tumori. 2001, 87 (3): 173-178. Epub 2001/08/16PubMed Markovic-Lipkovski J, Brasanac D, Muller GA, Muller CA: Cadherins and integrins in renal cell carcinoma: an immunohistochemical study. Tumori. 2001, 87 (3): 173-178. Epub 2001/08/16PubMed
18.
go back to reference Eble JN: International Agency for Research on Cancer. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC-Press. 2004, 359: S p-S p Eble JN: International Agency for Research on Cancer. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC-Press. 2004, 359: S p-S p
19.
go back to reference Hatta K, Takagi S, Fujisawa H, Takeichi M: Spatial and temporal expression pattern of N-cadherin cell adhesion molecules correlated with morphogenetic processes of chicken embryos. Dev Biol. 1987, 120 (1): 215-227. 10.1016/0012-1606(87)90119-9. Epub 1987/03/01CrossRefPubMed Hatta K, Takagi S, Fujisawa H, Takeichi M: Spatial and temporal expression pattern of N-cadherin cell adhesion molecules correlated with morphogenetic processes of chicken embryos. Dev Biol. 1987, 120 (1): 215-227. 10.1016/0012-1606(87)90119-9. Epub 1987/03/01CrossRefPubMed
20.
go back to reference Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA: Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol. 2000, 148 (4): 779-790. 10.1083/jcb.148.4.779. Epub 2000/02/23CrossRefPubMedPubMedCentral Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA: Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol. 2000, 148 (4): 779-790. 10.1083/jcb.148.4.779. Epub 2000/02/23CrossRefPubMedPubMedCentral
21.
go back to reference Kalluri R: EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest. 2009, 119 (6): 1417-1419. 10.1172/JCI39675. Epub 2009/06/03CrossRefPubMedPubMedCentral Kalluri R: EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest. 2009, 119 (6): 1417-1419. 10.1172/JCI39675. Epub 2009/06/03CrossRefPubMedPubMedCentral
22.
go back to reference Harada KI, Miyake H, Kusuda Y, Fujisawa M: Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy. BJU Int. 2012,  -Epub 2012/06/21 Harada KI, Miyake H, Kusuda Y, Fujisawa M: Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy. BJU Int. 2012,  -Epub 2012/06/21
23.
go back to reference Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ: N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol. 1999, 147 (3): 631-644. 10.1083/jcb.147.3.631. Epub 1999/11/05CrossRefPubMedPubMedCentral Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ: N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol. 1999, 147 (3): 631-644. 10.1083/jcb.147.3.631. Epub 1999/11/05CrossRefPubMedPubMedCentral
24.
go back to reference Polyak K, Weinberg RA: Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009, 9 (4): 265-273. 10.1038/nrc2620. Epub 2009/03/06CrossRefPubMed Polyak K, Weinberg RA: Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009, 9 (4): 265-273. 10.1038/nrc2620. Epub 2009/03/06CrossRefPubMed
25.
go back to reference Thomson S, Buck E, Petti F, Griffin G, Brown E, Ramnarine N: Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. Cancer Res. 2005, 65 (20): 9455-9462. 10.1158/0008-5472.CAN-05-1058. Epub 2005/10/19CrossRefPubMed Thomson S, Buck E, Petti F, Griffin G, Brown E, Ramnarine N: Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. Cancer Res. 2005, 65 (20): 9455-9462. 10.1158/0008-5472.CAN-05-1058. Epub 2005/10/19CrossRefPubMed
26.
go back to reference Han AC, Soler AP, Knudsen KA, Salazar H: Distinct cadherin profiles in special variant carcinomas and other tumors of the breast. Hum Pathol. 1999, 30 (9): 1035-1039. 10.1016/S0046-8177(99)90220-4. Epub 1999/09/24CrossRefPubMed Han AC, Soler AP, Knudsen KA, Salazar H: Distinct cadherin profiles in special variant carcinomas and other tumors of the breast. Hum Pathol. 1999, 30 (9): 1035-1039. 10.1016/S0046-8177(99)90220-4. Epub 1999/09/24CrossRefPubMed
27.
go back to reference Wheelock MJ, Shintani Y, Maeda M, Fukumoto Y, Johnson KR: Cadherin switching. J Cell Sci. 2008, 121 (Pt 6): 727-735. Epub 2008/03/07CrossRefPubMed Wheelock MJ, Shintani Y, Maeda M, Fukumoto Y, Johnson KR: Cadherin switching. J Cell Sci. 2008, 121 (Pt 6): 727-735. Epub 2008/03/07CrossRefPubMed
28.
go back to reference Honecker F, Kersemaekers AM, Molier M, Van Weeren PC, Stoop H, De Krijger RR: Involvement of E-cadherin and beta-catenin in germ cell tumours and in normal male fetal germ cell development. J Pathol. 2004, 204 (2): 167-174. 10.1002/path.1614. Epub 2004/09/21CrossRefPubMed Honecker F, Kersemaekers AM, Molier M, Van Weeren PC, Stoop H, De Krijger RR: Involvement of E-cadherin and beta-catenin in germ cell tumours and in normal male fetal germ cell development. J Pathol. 2004, 204 (2): 167-174. 10.1002/path.1614. Epub 2004/09/21CrossRefPubMed
29.
go back to reference Saito T, Katagiri A, Watanabe R, Tanikawa T, Kawasaki T, Tomita Y: Expression of E-cadherin and catenins on testis tumor. Urol Int. 2000, 65 (3): 140-143. 10.1159/000064859. Epub 2000/10/29CrossRefPubMed Saito T, Katagiri A, Watanabe R, Tanikawa T, Kawasaki T, Tomita Y: Expression of E-cadherin and catenins on testis tumor. Urol Int. 2000, 65 (3): 140-143. 10.1159/000064859. Epub 2000/10/29CrossRefPubMed
30.
go back to reference Hart AH, Hartley L, Parker K, Ibrahim M, Looijenga LH, Pauchnik M: The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer. 2005, 104 (10): 2092-2098. 10.1002/cncr.21435. Epub 2005/10/06CrossRefPubMed Hart AH, Hartley L, Parker K, Ibrahim M, Looijenga LH, Pauchnik M: The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer. 2005, 104 (10): 2092-2098. 10.1002/cncr.21435. Epub 2005/10/06CrossRefPubMed
31.
go back to reference Niehans GA, Manivel JC, Copland GT, Scheithauer BW, Wick MR: Immunohistochemistry of germ cell and trophoblastic neoplasms. Cancer. 1988, 62 (6): 1113-1123. 10.1002/1097-0142(19880915)62:6<1113::AID-CNCR2820620614>3.0.CO;2-0. Epub 1988/09/15CrossRefPubMed Niehans GA, Manivel JC, Copland GT, Scheithauer BW, Wick MR: Immunohistochemistry of germ cell and trophoblastic neoplasms. Cancer. 1988, 62 (6): 1113-1123. 10.1002/1097-0142(19880915)62:6<1113::AID-CNCR2820620614>3.0.CO;2-0. Epub 1988/09/15CrossRefPubMed
32.
go back to reference Bentley AJ, Parkinson MC, Harding BN, Bains RM, Lantos PL: A comparative morphological and immunohistochemical study of testicular seminomas and intracranial germinomas. Histopathology. 1990, 17 (5): 443-449. 10.1111/j.1365-2559.1990.tb00766.x. Epub 1990/11/01CrossRefPubMed Bentley AJ, Parkinson MC, Harding BN, Bains RM, Lantos PL: A comparative morphological and immunohistochemical study of testicular seminomas and intracranial germinomas. Histopathology. 1990, 17 (5): 443-449. 10.1111/j.1365-2559.1990.tb00766.x. Epub 1990/11/01CrossRefPubMed
33.
go back to reference Leroy X, Augusto D, Leteurtre E, Gosselin B: CD30 and CD117 (c-kit) used in combination are useful for distinguishing embryonal carcinoma from seminoma. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society. 2002, 50 (2): 283-285. 10.1177/002215540205000216. Epub 2002/01/19CrossRef Leroy X, Augusto D, Leteurtre E, Gosselin B: CD30 and CD117 (c-kit) used in combination are useful for distinguishing embryonal carcinoma from seminoma. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society. 2002, 50 (2): 283-285. 10.1177/002215540205000216. Epub 2002/01/19CrossRef
34.
go back to reference Jones TD, Ulbright TM, Eble JN, Baldridge LA, Cheng L: OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol. 2004, 28 (7): 935-940. 10.1097/00000478-200407000-00014. Epub 2004/06/30CrossRefPubMed Jones TD, Ulbright TM, Eble JN, Baldridge LA, Cheng L: OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol. 2004, 28 (7): 935-940. 10.1097/00000478-200407000-00014. Epub 2004/06/30CrossRefPubMed
35.
go back to reference Eglen DE, Ulbright TM: The differential diagnosis of yolk sac tumor and seminoma. Usefulness of cytokeratin, alpha-fetoprotein, and alpha-1-antitrypsin immunoperoxidase reactions. Am J Clin Pathol. 1987, 88 (3): 328-332. Epub 1987/09/01CrossRefPubMed Eglen DE, Ulbright TM: The differential diagnosis of yolk sac tumor and seminoma. Usefulness of cytokeratin, alpha-fetoprotein, and alpha-1-antitrypsin immunoperoxidase reactions. Am J Clin Pathol. 1987, 88 (3): 328-332. Epub 1987/09/01CrossRefPubMed
36.
go back to reference Suster S, Moran CA, Dominguez-Malagon H, Quevedo-Blanco P: Germ cell tumors of the mediastinum and testis: a comparative immunohistochemical study of 120 cases. Hum Pathol. 1998, 29 (7): 737-742. 10.1016/S0046-8177(98)90284-2. Epub 1998/07/22CrossRefPubMed Suster S, Moran CA, Dominguez-Malagon H, Quevedo-Blanco P: Germ cell tumors of the mediastinum and testis: a comparative immunohistochemical study of 120 cases. Hum Pathol. 1998, 29 (7): 737-742. 10.1016/S0046-8177(98)90284-2. Epub 1998/07/22CrossRefPubMed
Metadata
Title
N-cadherin expression in malignant germ cell tumours of the testis
Authors
Felix Bremmer
Bernhard Hemmerlein
Arne Strauss
Peter Burfeind
Paul Thelen
Heinz-Joachim Radzun
Carl Ludwig Behnes
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Clinical Pathology / Issue 1/2012
Electronic ISSN: 1472-6890
DOI
https://doi.org/10.1186/1472-6890-12-19

Other articles of this Issue 1/2012

BMC Clinical Pathology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine